
|Articles|January 1, 2003
Leukocytoclastic Vasculitis
Paris - Certain clinical and laboratory features appear to be useful markers for determining the prognosis of leukocytoclastic vasculitis, and so their identification can be helpful for guiding patient evaluation and management, Jordi Peyri, M.D., said at the World Congress of Dermatology.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
3
Dermatology Conferences and Meetings Calendar: December 2025
4
ICYMI: First Patient Dosed in Global Phase 2 Study of Oral TYK2 Inhibitor Soficitinib for PN
5


















